We scan new podcasts and send you the top 5 insights daily.
The absence of significant flaws or negative perspectives on a deal is a red flag, suggesting something was missed in diligence. True exceptionality is what carries a great investment, not a lack of risk. If everyone agrees it's a great deal, you're likely too late or wrong.
An investor might correctly identify a company's flaw but still be wrong to pass, as great founders often fix those issues. This requires investors to have the humility to admit their ultimate conclusion was wrong, even if their initial analysis was correct, and be willing to re-engage with the startup.
Effective due diligence isn't a checklist, but the collection of many small data points—revenue, team retention, customer love, CVC interest. A strong investment is a "beam" where all points align positively. Any misalignment creates doubt and likely signals a "no," adhering to the "if it's not a hell yes, it's a no" rule.
Early-stage deal diligence often fails due to inconsistencies in the overall story. Red flags include a lack of transparency, financials that don't add up, and misaligned team vision. These narrative cracks signal deeper issues more effectively than any single weak KPI.
In venture capital, a portfolio with no failed investments is a sign of a flawed, risk-averse strategy. The goal isn't to avoid losses but to back the market leader in a potentially huge category. Losing money on the leader if the entire category fails is an acceptable and expected outcome.
Top VCs' biggest regrets come from passing on genuinely 'great' founders over solvable diligence issues. Mike Maples Jr. advises that when you encounter this rare trait, you should invest immediately, even if the business model is unclear.
To avoid becoming emotionally invested in a deal, it's crucial to institutionalize a "devil's advocate" role. Proactively searching for reasons *not* to do the deal ensures a sober, realistic assessment. The final decision is a calculated risk based on incomplete (e.g., 80%) information.
Investor Chris Reisach argues that if an investment doesn't make sense to you, the problem likely lies with the business, not your intellect. He advises junior VCs to trust their confusion as an adverse signal. A founder's inability to clearly articulate their vision is a fundamental flaw, and investing without true conviction is a recipe for failure.
The romantic notion of discovering a completely unknown, brilliant company is largely an investor ego trip. In a competitive market, great companies attract attention. So-called "diamonds in the rough" are often overlooked for valid reasons, such as a fundamental business flaw or a difficult founder.
The pursuit of a "diamond in the rough" is an investor ego trap. Andreessen argues that great companies are obvious "diamonds" that attract widespread interest. A deal that seems undiscovered is often "in the rough" for a good reason, like a flawed structure or a hyper-disagreeable founder who has alienated other firms.
When evaluating a deal sponsor, favor those who are reflective over those who are purely sales-oriented. The best sponsors demonstrate transparency and thoughtfulness by proactively highlighting a deal's risks on the first slide, rather than trying to hide weaknesses to secure a management fee.